Active
ESBE - PHARMA logo

ESBE - PHARMA

Switched

BE0430045342

Rechtspersoon Private limited company 1 establishment

Grand-Rue 20, 6200 Châtelet Detailhandel in farmaceutische producten esbepharma.be

Active for

39 year, 8 months

Financials

Financial year 2025

Gross margin

€ 187,634

▲ 10% vs 2024

Profit

Growing

€ 113,949

▲ 12% vs 2024

Debts

Low

€ 68,363

▼ 6% vs 2024

ESBE - PHARMA from Châtelet, company number BE0430045342, closed financial year 2025 with a result of € 113,949 after tax. For that financial year ESBE - PHARMA recorded a gross margin of € 187,634 and equity of € 739,799. Compared with financial year 2024, the result moved from € 101,464 to € 113,949. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What happened at ESBE - PHARMA?

What happened at ESBE - PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 113,949 (▲ 12% vs 2024). Source: NBB ↗
  • New establishment in Châtelet. KBO
  • Start of the company according to the CBE. KBO

In short

From € 46,928 profit in 2021 to € 113,949 profit in 2025.

Paid € 195,724 in corporate taxes since 2021.

Best year ever: 2025, with € 113,949 profit.

A new publication or filing at ESBE - PHARMA? We notify you, reason included.

Follow ESBE - PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

KARINE SPREUTELS
MICHEL BREDA
ESBE - PHARMA

Behind ESBE - PHARMA are KARINE SPREUTELS and MICHEL BREDA.

See the full network in the app

Directors

According to the 2025 annual accounts

KARINE SPREUTELS

Director

MICHEL BREDA

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Grand-Rue 20

6200 Châtelet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Advanced Custom FieldsApacheElementorFont AwesomeGoogle FontsGoogle MapsPHPPWASwiperWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

HETZNER-AS, DE

Website info

HTTPS Ja
Languages FR
Copyright 2026

Features

Webshop Blog Contact page

Security

HTTPS
SPF
DMARC

Network

IPv6

Details

Company number
0430.045.342
VAT number
BE 0430.045.342
Registered office
Grand-Rue 20, 6200 Châtelet
Names & denominations
ESBE - PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
11 December 1986
Peppol
Active · Active since 13 Dec 2025
Contact
esbepharma.be
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of ESBE - PHARMA?
The enterprise number of ESBE - PHARMA is BE0430045342.
What is the address of ESBE - PHARMA?
The registered office of ESBE - PHARMA is located at Grand-Rue 20, 6200 Châtelet.
When was ESBE - PHARMA founded?
ESBE - PHARMA was founded on 11 December 1986.
What is the main activity of ESBE - PHARMA?
The main activity of ESBE - PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does ESBE - PHARMA have a website?
Yes, ESBE - PHARMA has a website at esbepharma.be.
Does ESBE - PHARMA have an online shop?
Yes, ESBE - PHARMA has an online shop.
Is ESBE - PHARMA active on social media?
No social media profiles are currently known for ESBE - PHARMA.
How much profit did ESBE - PHARMA make in 2025?
ESBE - PHARMA posted a profit after taxes of € 113,949 in financial year 2025.
What is the revenue of ESBE - PHARMA?
As a small company, ESBE - PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 187,634.
Where can I find the annual accounts of ESBE - PHARMA?
ESBE - PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ESBE - PHARMA?
According to the 2025 annual accounts, the directors of ESBE - PHARMA are: KARINE SPREUTELS, MICHEL BREDA.
Who owns ESBE - PHARMA?
Behind ESBE - PHARMA are KARINE SPREUTELS and MICHEL BREDA.